Patents by Inventor Claus Hansen

Claus Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALOALKYLSULFONE SUBSTITUTED COMPOUNDS USEFUL FOR TREATING OBESITY AND DIABETES
    Publication number: 20100041657
    Abstract: The present invention relates to compounds of formula I, in which at least one of R5, R6 and R7 is SR12, S(O)R12 or S(O)2R12 group where R12 is a C1-6haloalkyl group, that act, as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith.
    Type: Application
    Filed: May 11, 2006
    Publication date: February 18, 2010
    Applicant: NOVO NORDICK A/S
    Inventors: Preben Houlberg Olesen, Holger Claus Hansen, Lise Brown Christiansen, Flemming Elmelund Nielsen, Anders Klarskov Petersen
  • Salicylic anilides
    Patent number: 7645791
    Abstract: Novel salicylic anilides are chemical uncouplers useful e.g. for the treatment of obesity.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: January 12, 2010
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Preben Houlberg Olesen, Thomas Kruse Hansen, Lise Brown Christiansen, Holger Claus Hansen
  • NOVEL 2-(2-HYDROXYPHENYL) BENZOTHIADIAZINES USEFUL FOR TREATING OBESITY AND DIABETES
    Publication number: 20090325941
    Abstract: The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith.
    Type: Application
    Filed: November 15, 2007
    Publication date: December 31, 2009
    Inventors: Anders Klarskov Petersen, Preben Houlberg Olesen, Lise Brown Christiansen, Holger Claus Hansen, Flemming Elmelund Nielsen
  • Novel Haloalkoxy-Substituted Salicylic Anilides
    Publication number: 20090062396
    Abstract: The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or disorders associated therewith.
    Type: Application
    Filed: May 23, 2006
    Publication date: March 5, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Preben Houlberg Olesen, Holger Claus Hansen, Lise Brown Christiansen, Anders Klarskov Petersen, Flemming Elmelund Nielsen, Birgit Sehested Hansen
  • Novel Salicylic Anilides
    Publication number: 20090005434
    Abstract: Novel salicylic anilides are chemical uncouplers useful e.g. for the treatment of obesity.
    Type: Application
    Filed: June 27, 2008
    Publication date: January 1, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Preben Houlberg Olesen, Thomas Kruse Hansen, Lise Brown Christiansen, Holger Claus Hansen
  • Sulfonamide Derivatives
    Publication number: 20080255240
    Abstract: Novel sulfon amide derivatives are chemical uncouplers useful e.g. for the treatment of obesity.
    Type: Application
    Filed: May 4, 2005
    Publication date: October 16, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Lise Brown Christiansen, Preben Houlberg Olesen, Holger Claus Hansen
  • Novel Trifluoromethoxy-Substituted Aryl Anilides
    Publication number: 20080234381
    Abstract: The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful in the treatment, including prevention, of obesity, diabetes and a number of diseases or disorders associated therewith.
    Type: Application
    Filed: May 23, 2006
    Publication date: September 25, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Preben Houlberg Olesen, Holger Claus Hansen, Lise Brown Christiansen, Anders Klarskov Petersen, Flemming Elmelund Nielsen, Birgit Sehested Hansen
  • Novel Neurotrophic Factors
    Publication number: 20080227703
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 18, 2008
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
    Patent number: 7279470
    Abstract: Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: October 9, 2007
    Assignee: Novo Nordisk A/S
    Inventors: Soren Ebdrup, Johannes Cornelis de Jong, Poul Jacobsen, Holger Claus Hansen, Per Vedso
  • Use of compounds for decreasing activity of hormone-sensitive lipase
    Patent number: 7067517
    Abstract: Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: June 27, 2006
    Assignee: Nero Nordisk A/S
    Inventors: Soren Ebdrup, Johannes Cornelis de Jong, Poul Jacobsen, Holger Claus Hansen, Per Vedso
  • Novel neurotrophic factors
    Publication number: 20040259779
    Abstract: The present invention relates to novel biologically active, processed forms of the neuronal survival and growth factor protein denominated NSG3, in particular the pro-protein, the mature protein and core fragment of NSG3, as well as variants thereof. Also, the use of the novel polypeptides for treating or preventing a neurodegenerative disease, in particular an excitotoxic disease, a cancer, tissue injury, insufficient bone cartilage growth and maturation or a disease involving muscle in an animal is described.
    Type: Application
    Filed: July 23, 2004
    Publication date: December 23, 2004
    Inventors: Teit Johansen, Nikolaj Blom, Claus Hansen
  • Novel neurotrophic factors
    Publication number: 20040230043
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Application
    Filed: March 22, 2004
    Publication date: November 18, 2004
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • Neublastin neurotrophic factors
    Patent number: 6734284
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: May 11, 2004
    Assignee: NsGene A/S
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • Lighting apparatus
    Publication number: 20030218881
    Abstract: An apparatus for modulating the color of a light beam includes an inner color wheel provided with outwardly directed color filters around its circumference and an outer color wheel provided with inwardly directed color filters around its rim. The color wheels contra-rotate about a common axis and are positioned such that the color filters of a respective color wheel only partially cover the light beam. A lighting effect can be achieved which gives the impression of a complex pattern of moving colors within a beam of light, using components which are relatively simple and inexpensive.
    Type: Application
    Filed: March 21, 2003
    Publication date: November 27, 2003
    Inventors: Claus Hansen, Jens Hansen
  • Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
    Publication number: 20030166644
    Abstract: Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
    Type: Application
    Filed: December 13, 2002
    Publication date: September 4, 2003
    Inventors: Soren Ebdrup, Johannes Cornelis de Jong, Poul Jacobsen, Holger Claus Hansen, Per Vedso
  • Use of compounds for decreasing activity of hormone-sensitive
    Publication number: 20030166690
    Abstract: Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.
    Type: Application
    Filed: December 13, 2002
    Publication date: September 4, 2003
    Inventors: Soren Ebdrup, Johannes Cornelis de Jong, Poul Jacobsen, Holger Claus Hansen, Per Vedso
  • Neurotrophic factors
    Patent number: 6593133
    Abstract: The invention relates to neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides, as well as methods of making and methods of using the same.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: July 15, 2003
    Assignee: NsGENE A/S
    Inventors: Teit E. Johansen, Nikolaj Blom, Claus Hansen
  • 1,2,4-benzothiadiazine derivatives, their preparation and use
    Patent number: 6242443
    Abstract: 1,2,4-Benzothiadiazine derivatives represented by formula wherein D, R1, R2, R3, R4, R5, R12, R13, R14, R15 are defined in the description, composition thereof and methods for preparing the compounds are described. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
    Type: Grant
    Filed: June 17, 1997
    Date of Patent: June 5, 2001
    Assignee: Novo Nordisk AIS
    Inventors: Bernard Pirotte, Philippe Lebrun, Pascal De Tullio, Fabian Somers, Jacques Delarge, John Bondo Hansen, Flemming Elmelund Nielsen, Holger Claus Hansen, John Patrick Mogensen, Tina Møller-Tagmose
  • Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
    Patent number: 6232310
    Abstract: The present invention relates to fused 1,4-thiazine-2-carbonitrile derivatives, compositions thereof and methods for preparing the compounds. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: May 15, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Holger Claus Hansen, Tina Møller Tagmose, John Bondo Hansen
  • Fused 1,2,4-thiadiazine derivatives, their preparation and use
    Patent number: 6225310
    Abstract: 1,2,4-Thiadiazine and 1,4-thiazine derivates represented by formula (I): wherein A, B, D, R1, R2, R3 and R4 are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
    Type: Grant
    Filed: March 30, 2000
    Date of Patent: May 1, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Flemming Elmelund Nielsen, John Bondo Hansen, Holger Claus Hansen, Tina Møller Tagmose, John Patrick Mogensen